Match!

A systematic overview of radiation therapy effects in cervical cancer (cervix uteri)

Published on Jan 1, 2003in Acta Oncologica3.298
· DOI :10.1080/02841860310014660
Nina Einhorn22
Estimated H-index: 22
(KI: Karolinska Institutet),
Claes G. Tropé57
Estimated H-index: 57
+ 3 AuthorsEva Cavallin-Ståhl37
Estimated H-index: 37
(Lund University)
Abstract
A systematic review of radiation therapy trials in several tumour types was performed by The Swedish Council of Technology Assessment in Health Care (SBU). The procedures for evaluation of the scientific literature are described separately (Acta Oncol 2003; 42: 357-365). This synthesis of the literature on radiation therapy for cervical cancer is based on data from 1 meta-analysis and 34 randomized trials. In total, 35 scientific articles are included, involving 7952 patients. The results were compared with those of a similar overview from 1996 including 34 024 patients. The conclusions reached can be summarized in these points: There are limited scientific data supporting that postoperative pelvic radiotherapy improves disease-free survival in early cervical cancer. No firm conclusion can be drawn. There is moderate scientific evidence that external beam radiotherapy combined with brachytherapy gives a similar disease-free and overall survival rate as radical hysterectomy in early cervical cancer. There is strong scientific evidence that concomitant radiochemotherapy improves disease-free and overall survival compared to radiotherapy alone in early cervical cancer. The NCI has recently published an announcement stating that cisplatin-based chemotherapy should be used concomitantly with radiotherapy in cervical cancer. No solid documentation for this statement can be found concerning locally advanced stages ( >IIB). There is a strong scientific evidence that cisplatin-based chemotherapy given concomitantly with radiotherapy is superior to concomitant chemotherapy with hydroxyurea. There is no scientific evidence to show that neoadjuvant chemotherapy followed by radiotherapy improves disease-free or overall survival compared to radiotherapy alone in patients with localized cervical cancer. There is moderate scientific evidence that high-dose-rate brachytherapy gives the same local control rate as low-dose-rate brachytherapy but with fewer rectal complications. (Less)
  • References (32)
  • Citations (29)
📖 Papers frequently viewed together
21 Citations
130 Citations
33 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References32
Newest
#1John Green (University of Liverpool)H-Index: 33
#2John M. KirwanH-Index: 4
Last. Chris Williams (Cochrane Collaboration)H-Index: 12
view all 7 authors...
Summary Background The US National Cancer Institute alert in February, 1999, stated that concomitant chemotherapy and radiotherapy should be considered for all patients with cervical cancer. Our aim was to review the effects of chemoradiotherapy on overall and progression-free survival, local and distant control, and acute and late toxicity in patients with cervical cancer. Methods With the methodology of the Cochrane Collaboration, we did a systematic review of all known randomised controlled t...
764 CitationsSource
#1William A. Peters (UCI: University of California, Irvine)H-Index: 2
#2P.Y. Liu (UCI: University of California, Irvine)H-Index: 4
Last. David S. AlbertsH-Index: 2
view all 10 authors...
PURPOSE: To determine whether the addition of cisplatin-based chemotherapy (CT) to pelvic radiation therapy (RT) will improve the survival of early-stage, high-risk patients with cervical carcinoma. PATIENTS AND METHODS: Patients with clinical stage IA2, IB, and IIA carcinoma of the cervix, initially treated with radical hysterectomy and pelvic lymphadenectomy, and who had positive pelvic lymph nodes and/or positive margins and/or microscopic involvement of the parametrium were eligible for this...
1,381 CitationsSource
#1Hiroshi OnishiH-Index: 28
#2Motoshi YamaguchiH-Index: 3
Last. Ito HH-Index: 1
view all 14 authors...
PURPOSE: The purpose of this study was to explore the effect of concurrent intra-arterial infusion of platinum drugs in patients with stage III or IV uterine cervical cancer treated with radical radiation therapy. PATIENTS AND METHODS: Thirty-three patients with advanced (stage IIIA, 2; IIIB, 28; IVA, 3) uterine cervical squamous cell carcinoma were randomized into a concurrent intra-arterial infusion of platinum drugs with radiation therapy (IAPRT) group (18 patients) and a radiation therapy al...
13 Citations
#1Stanley Dische (Mount Vernon Hospital)H-Index: 48
#2Michele I. Saunders (Mount Vernon Hospital)H-Index: 41
Last. Søren M. Bentzen (Mount Vernon Hospital)H-Index: 79
view all 7 authors...
Abstract Background and purpose : A randomised controlled trial of hyperbaric oxygen in the radiotherapy of Stage IIb and III carcinoma of cervix was performed between 1971 and 1980. Apart from an abstract giving an interim report in 1977, results have not been published. Material and methods : In a four arm study, 335 patients were randomised to treatment in 10 or 28 fractions, in hyperbaric oxygen or in air. Data is available concerning 327 cases and this has been analysed. Results : There was...
38 CitationsSource
#1Faith R. Viswanathan (Christian Medical College & Hospital)H-Index: 3
#2Cherian VargheseH-Index: 3
Last. Viswanathan Perungulam Narayan (Christian Medical College & Hospital)H-Index: 1
view all 5 authors...
Abstract Purpose: Hyperfractionation has been advocated to improve local tumor control by increasing radiation dose without increasing late normal tissue complications. The aim of this study was to determine if hyperfractionation decreased late bowel complications. Methods and Materials: Thirty patients with Stage II and III cervical cancer were randomized to receive either hyperfractionation or conventional fractionation. Patients were followed for 5 years and monitored for tumor control, recur...
9 CitationsSource
#1Ling-Chui WongH-Index: 19
#2H. Y.S. NganH-Index: 1
Last. Damon ChoyH-Index: 39
view all 6 authors...
PURPOSE: Radiotherapy is the standard treatment for locally advanced cervical cancer, but treatment results remain disappointing, particularly for women with bulky central disease. We investigated the role of concurrent chemoradiation and adjuvant chemotherapy in a randomized trial. PATIENTS AND METHODS: Two hundred twenty patients with bulky stage I, II, and III cervical cancer were randomized to receive either standard pelvic radiotherapy or chemoradiation (epirubicin 60 mg/m2) followed by adj...
103 CitationsSource
#1Manfred Lahousen (University of Graz)H-Index: 27
#2Josef Haas (University of Graz)H-Index: 29
Last. Raimund Winter (University of Graz)H-Index: 33
view all 8 authors...
Abstract Background. Adjuvant treatment modalities after radical hysterectomy have long been used in an attempt to eradicate microscopic tumor residuals in patients at high risk for recurrence. However, it has not been clearly demonstrated that adjuvant radiation, adjuvant chemotherapy, or both improve the outcome. To evaluate the effect of adjuvant treatment in patients with high-risk cervical cancer after radical hysterectomy, the Austrian Gynecologic Oncology Group conducted a prospective, ra...
54 CitationsSource
#1Alexander Sedlis (SUNY Downstate Medical Center)H-Index: 24
#2Brian N. Bundy (Roswell Park Cancer Institute)H-Index: 31
Last. Richard J. Zaino (Penn State Milton S. Hershey Medical Center)H-Index: 54
view all 6 authors...
Abstract Objective. The objective of this study was to evaluate the benefits and risk of adjuvant pelvic radiotherapy aimed at reducing recurrence in women with Stage IB cervical cancer treated by radical hysterectomy and pelvic lymphadenectomy. Methods. Two hundred seventy-seven eligible patients were entered with at least two of the following risk factors: >1/3 stromal invasion, capillary lymphatic space involvement, and large clinical tumor diameter. Of 277 patients, 137 were randomized to pe...
632 CitationsSource
#1Charles W. WhitneyH-Index: 21
#2William T. SauseH-Index: 49
Last. Shu Yuan LiaoH-Index: 10
view all 8 authors...
PURPOSE: In 1986, a protocol comparing primary radiation therapy (RT) plus hydroxyurea (HU) to irradiation plus fluorouracil (5-FU) and cisplatin (CF) was activated by the Gynecologic Oncology Group (GOG) for the treatment of patients with locally advanced cervical carcinoma. The goals were to determine the superior chemoradiation regimen and to quantitate the relative toxicities. METHODS: All patients had biopsy-proven invasive squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma...
1,077 CitationsSource
#1Mitchell Morris (University of Texas MD Anderson Cancer Center)H-Index: 47
#2Patricia J. EifelH-Index: 55
Last. D.G. Mutch (NYU: New York University)H-Index: 11
view all 9 authors...
Background and Methods We compared the effect of radiotherapy to a pelvic and para-aortic field with that of pelvic radiation and concurrent chemotherapy with fluorouracil and cisplatin in women with advanced cervical cancer. Between 1990 and 1997, 403 women with advanced cervical cancer confined to the pelvis (stages IIB through IVA or stage IB or IIA with a tumor diameter of at least 5 cm or involvement of pelvic lymph nodes) were randomly assigned to receive either 45 Gy of radiation to the p...
1,624 CitationsSource
Cited By29
Newest
#1A.J.M. Rombouts (Radboud University Nijmegen)H-Index: 5
#2Niek Hugen (Radboud University Nijmegen)H-Index: 10
Last. Iris D. Nagtegaal (Radboud University Nijmegen)H-Index: 59
view all 6 authors...
Abstract Background One of the late complications associated with radiation therapy (RT) is a possible increased risk of second cancer. In this systematic review, we analysed the incidence of rectal cancer following primary pelvic cancer irradiation. Methods A literature search was conducted using the PubMed and EMBASE libraries. Original articles that reported on secondary rectal cancer after previous RT for a primary pelvic cancer were included. Sensitivity analyses were performed by correctin...
5 CitationsSource
#1James R. Cardinal (UofU: University of Utah)H-Index: 1
#2Austen Slade (UofU: University of Utah)H-Index: 1
Last. Jeremy B. Myers (UofU: University of Utah)H-Index: 16
view all 6 authors...
Purpose of review To critically review and summarize existing literature assessing the effectiveness of hyperbaric oxygen therapy (HBOT) for the treatment of radiation-induced urologic injury.
3 CitationsSource
Resumo Objetivo Devido a sua morbilidade e mortalidade consideraveis, a cistite radica hemorragica e uma importante complicacao da radioterapia pelvica, tendo os atuais tratamentos conservadores uma eficacia muito limitada. O oxigenio hiperbarico tem vindo a demonstrar eficacia no tratamento de lesoes induzidas por radiacao, como a cistite radica. Pretende‐se analisar a eficacia e o perfil de seguranca da oxigenoterapia hiperbarica na cistite radica hemorragica refrataria. Material e metodos Ana...
Source
#1Haibin Chen (Southern Medical University)H-Index: 4
#2Zichun Zhong (WSU: Wayne State University)H-Index: 8
Last. Xuejun GuH-Index: 23
view all 9 authors...
GEC-ESTRO guidelines for high dose rate cervical brachytherapy advocate the reporting of the D2cc (the minimum dose received by the maximally exposed 2cc volume) to organs at risk. Due to large interfractional organ motion, reporting of accurate cumulative D2cc over a multifractional course is a non-trivial task requiring deformable image registration and deformable dose summation. To efficiently and accurately describe the point-to-point correspondence of the bladder wall over all treatment fra...
5 CitationsSource
Objectives To analyze the efficacy of hyperbaric oxygen for the treatment of radiation-induced hemorrhagic cystitis and to identify factors associated with successful treatment. Methods Clinical records from 176 patients with refractory radiation-induced hemorrhagic cystitis treated at the Portuguese Navy Center for Underwater and Hyperbaric Medicine, during a 15-year period, were retrospectively analyzed. Evolution of macroscopic hematuria was used to analyze treatment efficacy and correlated w...
13 CitationsSource
Source
#1Tara Rosewall (CSU: Charles Sturt University)H-Index: 16
#2Marc Potvin (U of T: University of Toronto)H-Index: 2
Last. Michael Milosevic (U of T: University of Toronto)H-Index: 58
view all 7 authors...
Abstract Introduction This literature review presents information relevant to medical radiation technologists with respect to new knowledge on the function of the urinary bladder. These new insights are also explored in relation to radiation-induced histopathological effects and the symptoms of bladder dysfunction reported after external beam radiotherapy. Methods and Materials The peer-reviewed scientific literature was examined using various electronic medical search engines with appropriate k...
3 CitationsSource
Objective Whereas pelvic exenteration is an established therapy for the treatment of recurrent cervical carcinoma, it is not often performed for primary locally advanced cervical cancer (LACC). Study Design This retrospective study analyzed survival data and prognostic factors of 35 patients with LACC who were treated by pelvic exenteration. Results After surgery, 33 patients (97%) were macroscopically free of tumor. In 20 patients, pelvic lymph nodes (LN) were involved, and in 6 of these, metas...
11 CitationsSource
#1Gabriella Macchia (CUA: The Catholic University of America)H-Index: 22
#2Gabriella Ferrandina (CUA: The Catholic University of America)H-Index: 55
Last. Alessio G. Morganti (CUA: The Catholic University of America)H-Index: 30
view all 10 authors...
Abstract Objective A phase I–II prospective clinical trial of adjuvant accelerated radiation therapy (ADA-RT-1 trial) was set up in order to investigate the feasibility and efficacy of a pelvic conformal radiotherapy technique with concomitant boost (CB technique) to the vaginal vault in high-risk uterine cancers. Methods Patients with uterine (endometrial cancer and sarcomas) and cervical neoplasm received external radiotherapy delivered in a short overall treatment time with a CB technique. Th...
5 CitationsSource
#1Ioannis I. Verginadis (UoI: University of Ioannina)H-Index: 13
#2Spyridon Karkabounas (UoI: University of Ioannina)H-Index: 10
Last. Konstantinos Charalabopoulos (UoI: University of Ioannina)H-Index: 24
view all 8 authors...
Abstract Nowadays, investigation for possible therapeutic applications of various metal-based drugs attracts the scientific interest worldwide. The triorganotin compound bis[triphenyltin(IV)](3-carboxy-pyridine-2-thionato) (SnMNA), was tested for its anti-proliferative and antitumor activities. Cytotoxic activity was assessed by Trypan blue and 3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide assay (MTT). SnMNA exhibited potent cytotoxic effects against leiomyosarcoma cells (LMS) and...
22 CitationsSource